A new product liability lawsuit filed against Johnson & Johnson includes allegations that Children’s Tylenol caused a patient to suffer liver failure, and the claim joins a growing number of Tylenol liver failure complaints brought in courts throughout the country in recent years. The Tylenol lawsuit was filed earlier this month as part of the federal multidistrict litigation (MDL), on behalf of Jacob Richardson, who allegedly suffered acute liver failure in 2011 after taking Children’s Tylenol Oral Suspension for just three days. If you have suffered liver failure complications that you believe to be associated with Tylenol or another potentially dangerous medication, our consumer advocates at the Consumer Justice Foundation can help put you in touch with an experienced product liability lawyer in your area.
Tylenol is one of the most widely-used pain relievers in the United States, used by millions of Americans to reduce fever and relieve everyday aches and pains. Unfortunately, the active ingredient in Tylenol is acetaminophen, which has been identified as a leading cause of liver injury in the U.S. According to the U.S. Food and Drug Administration (FDA), acetaminophen may actually be responsible for more than 50,000 emergency room visits every year, including 25,000 hospitalizations and close to 500 deaths. In light of this risk, efforts have been launched in recent years to increase awareness about and curb the rate of liver injury associated with the popular pain reliever, which is also found in a number of prescription painkillers and over-the-counter cold medications.
In 2011, Johnson & Johnson reduced the maximum recommended dosage on Tylenol and other acetaminophen-containing products from 4,000 mg to 3,000 mg, after the FDA announced new acetaminophen limits affecting painkillers like Percocet and Vicodin. However, a growing number of lawsuits claim that the Johnson & Johnson has for decades withheld important safety information from consumers, concealing the risk of liver injury and liver failure allegedly associated with Tylenol and other acetaminophen-based medications.
The latest Tylenol liver failure suit, which names as defendants Johnson & Johnson, McNeil Consumer Healthcare and McNeil-PPC Inc., includes allegations of strict liability, negligent failure to warn, breach of warranty, negligence, negligent misrepresentation, negligent design defect, fraudulent concealment, fraud, and violations of consumer protection laws. In the complaint, the plaintiff claims that the companies responsible for manufacturing the acetaminophen-based pain reliever failed to provide adequate warnings about the risk of liver damage possibly resulting in the need for a liver transplant. If you believe you have been adversely affected by Johnson & Johnson’s Tylenol pain reliever, consult a product liability attorney in your area to explore your possible compensation options.